Professor Alberto Bernabe -
The John Marshall Law School
Tuesday, December 15, 2009
Drugmaker has paid about $1 billion to settle cases and more cases are pending
Drugmaker GlaxoSmithKline has reportedly paid about $1 billion to settle Paxil lawsuits, including claims that their antidepressant caused birth defects, suicides, addiction and other problems. However, with another 600 Paxil birth defect lawsuits still pending, the company is likely to spend substantially more to satisfy jury verdicts or settle all Paxil cases. Go to AboutLawsuits.com for the full story.